1. Home
  2. CTXR vs GREE Comparison

CTXR vs GREE Comparison

Compare CTXR & GREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.71

Market Cap

20.1M

Sector

Health Care

ML Signal

HOLD

Logo Greenidge Generation Holdings Inc.

GREE

Greenidge Generation Holdings Inc.

HOLD

Current Price

$1.24

Market Cap

20.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTXR
GREE
Founded
2007
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
20.1M
20.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTXR
GREE
Price
$0.71
$1.24
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
491.0K
129.8K
Earning Date
02-13-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,944,111.00
$62,115,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$147.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.58
52 Week High
$2.97
$2.42

Technical Indicators

Market Signals
Indicator
CTXR
GREE
Relative Strength Index (RSI) 39.15 42.30
Support Level $0.70 $1.09
Resistance Level $0.95 $1.35
Average True Range (ATR) 0.08 0.12
MACD 0.01 0.00
Stochastic Oscillator 10.92 47.08

Price Performance

Historical Comparison
CTXR
GREE

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

Share on Social Networks: